Product Information
QUILLIVANT XR 25 MG/5 ML SUSP is a brand product labeled by NextWave Pharmaceuticals, Inc, priced at $5.3978 per ML under NDC 24478032102. Its NADAC has been published 401 times since Oct 24, 2018.
Strength
300 mg/60mL
Manufacturer
NextWave Pharmaceuticals, IncNDC
24478032102
Classification
Brand
Dosage Form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA202100On Market Since
10/1/2012
Pharmacological Classes
Price Statistics
The NADAC for QUILLIVANT XR 25 MG/5 ML SUSP has been published 401 times since Oct 24, 2018, and over the history we have for it it has risen 23.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3978 per ML |
|---|---|
| All-time high | $5.4188 (Mar 13, 2024) |
| All-time low | $4.3595 (Oct 24, 2018) |
| 52-week high | $5.4088 |
| 52-week low | $5.3944 |
| Median price | $5.4000 |
| Average price | $5.1866 |
| Largest weekly change | +9.9% (Jan 8, 2020) |
| Weeks tracked | 401 |
| Tracking since | Oct 24, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the methylphenidate hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of QUILLIVANT XR 25 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for QUILLIVANT XR 25 MG/5 ML SUSP, manufactured by NextWave Pharmaceuticals, Inc, is $5.3978 per ML (NDC 24478032102), effective Jun 24, 2026.
How has the price of QUILLIVANT XR 25 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for QUILLIVANT XR 25 MG/5 ML SUSP has risen 23.8%. It has been tracked across 401 weekly CMS publications since Oct 24, 2018.
What are the highest and lowest recorded NADAC prices for QUILLIVANT XR 25 MG/5 ML SUSP?
Since Oct 24, 2018, the NADAC for QUILLIVANT XR 25 MG/5 ML SUSP has ranged from a low of $4.3595 (Oct 24, 2018) to a high of $5.4188 (Mar 13, 2024), with a median of $5.4000 per ML.
Are there cheaper alternatives to QUILLIVANT XR 25 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of QUILLIVANT XR 25 MG/5 ML SUSP, so no direct lower-cost alternative is listed.
Who manufactures QUILLIVANT XR 25 MG/5 ML SUSP?
QUILLIVANT XR 25 MG/5 ML SUSP (NDC 24478032102) is labeled by NextWave Pharmaceuticals, Inc, and CMS classifies it as a brand product.
Related Drugs
Same classification